The anti-aging market is predicated to grow to over $60 billion U.S. by 2027 as the quest for the fountain of youth continues. This company is entering the market with a unique product that targets stem cell support.
Emergent Health Corp. (OTC PINK:EMGE) announced in a press release the introduction of its newest product “Infinity Plus Multi™”, a unique proprietary product. The supplement will be available next month and targets Adult Stem Cell Support, Telomere Support and Specialized Ant-Aging Oxidants.
As the body ages, the number and quality of stem cells decline, increasing age-related challenges. On top of this, environmental toxins, lack of sleep and stress add to the negative impact on the body’s natural stem cell system of repair. This new product will support stem cell’s as they attempt to repair, restore and renew new cells.
Shares closed Wednesday trade at $0.033.